Cell Therapy: A New M&A Frontier
Cellares co-founder and CEO Fabian Gerlinghaus shares his unique approach to developing successful cell therapies
Healthcare
AI Creates a Flurry of M&A Activity in Healthcare RCM and HCIT
From PE investors to strategic acquirers, AI is fueling M&A activity within RCM and HCIT
Taking the Pulse of Healthcare M&A with Twin Brook’s Tim Wentink
This episode is brought to you by Twin Brook Capital Partners, a leading direct lending finance company focused on providing cash-flow based financing solutions for the middle market private equity community
Manufacturing M&A Success Among Gene and Cell Therapy Innovators
Investors look beyond product success to overcome the supply chain challenges of lifesaving therapy development
PE Weekly: Dealmakers Turn to Healthcare in a Slow Week for M&A
Middle-market dealmakers close out May with a slow week for M&A, but healthcare finishes the month strong
Thematic Investing Brings PE to the Clinical Trials Market
COVID-19 shone a light on a fragmented market. Now private equity firms are building platforms of clinical site businesses with an eye toward improving diversity.
Navigating Human Capital Challenges in Healthcare M&A
Insperity and Medaxion discuss their collaboration on seamless healthcare rollups
Scaling Physician Practices to Increase Value
Fulcrum Equity Partners' Chad Hooker discusses how to strengthen the relationship between physician practices and growth equity investors
Finding Value in Healthcare
Value-based care and healthcare IT continued to draw investors in the first quarter of 2022, as companies and sponsors work to build bigger platforms
Six Macro Trends Shaping Healthcare M&A
Industry changes translate into investment opportunities